ABLEXIS
Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, was founded in December 2009, based on technology principles established by its subsidiary, Aliva Biopharmaceuticals, Inc.
ABLEXIS
Industry:
Biotechnology Health Care Medical Device
Founded:
2009-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.ablexis.com
Total Employee:
1+
Status:
Active
Contact:
(415) 967-1220
Total Funding:
12 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Tag Manager WordPress Apache Wordpress Plugins Mobile Non Scaleable Content Sitelinks Search Box
Similar Organizations
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Current Advisors List
Board_member
Board_member
Board_member
Current Employees Featured
Larry Green CEO @ Ablexis
CEO
2009-12-01
Hiroaki Shizuya Founder @ Ablexis
Founder
Founder
Investors List
Third Rock Ventures
Third Rock Ventures investment in Series A - Ablexis
Pfizer Venture Investments
Pfizer Venture Investments investment in Series A - Ablexis
Official Site Inspections
http://www.ablexis.com Semrush global rank: 5.83 M Semrush visits lastest month: 1.43 K
- Host name: ablexis.com
- IP address: 72.52.86.106
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Ablexis"
About - Ablexis Ablexis A superior, next generation …
AlivaMab Biologics leverages the AlivaMab Mouse, developed by Ablexis as the platform for discovery projects conducted on behalf of clients. AlivaMab Biologics was established as a company separate from Ablexis in response to many …See details»
Ablexis - Crunchbase Company Profile & Funding
Ablexis is a biotechnology company developing an innovative, next-generation platform for antibody drug discovery.See details»
Ablexis, LLC - LinkedIn
Ablexis, LLC | 522 followers on LinkedIn. A superior, next generation transgenic platform. | Ablexis offers the AlivaMab® Mouse platform, a suite of transgenic mouse strains for human therapeutic ...See details»
Ablexis 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Ablexis. Use the PitchBook Platform to explore the full profile.See details»
Ablexis - VentureRadar
"Ablexis, LLC, a biotechnology company dedicated to licensing the AlivaMab Mouse, an innovative, next-generation platform for antibody drug discovery, was founded in December …See details»
Ablexis, LLC - San Diego, USA - bionity.com
In May 2018, Ablexis' founder and Deerfield Management founded AlivaMab Discovery Services, an independent contract research organization that provides antibody drug discovery services …See details»
Ablexis Company Profile - Office Locations, Competitors ... - Craft
Ablexis has 5 employees at their 1 location and $12 m in total funding,. See insights on Ablexis including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
ABLEXIS LLC Company Profile | San Francisco, CA | Competitors ...
Find company research, competitor information, contact details & financial data for ABLEXIS LLC of San Francisco, CA. Get the latest business insights from Dun & Bradstreet.See details»
Ablexis, LLC | Scientist.com
Ablexis, LLC, a biotechnology company dedicated to licensing the AlivaMab Mouse, an innovative, next-generation platform for antibody drug discovery, was founded in December …See details»
Ablexis - Funding, Financials, Valuation & Investors - Crunchbase
Ablexis is a biotechnology company developing an innovative, next-generation platform for antibody drug discovery.See details»
Contact - Ablexis
Info@ablexis.com phone 415.967.1220 Delivering a superior, next generation platform for the discovery of therapeutic antibodies.See details»
Ablexis & AlivaMab Discovery Services.pdf
Unparalleled success in antibody discovery and development. Ablexis and AlivaMab Discovery Services together launch antibody drug discovery and development projects on the fastest and …See details»
Ablexis and AlivaMab Discovery Services Announce Expansion of …
About Ablexis, LLC Ablexis, LLC created and non-exclusively licenses AlivaMab Mouse, an expanding suite of unique, patented next generation transgenic mice, as a platform for human …See details»
Ablexis - Updates, News, Events, Signals & Triggers - Crunchbase
Ablexis is a biotechnology company developing an innovative, next-generation platform for antibody drug discovery.See details»
Ablexis - Contacts, Employees, Board Members, Advisors & Alumni
Ablexis is a biotechnology company developing an innovative, next-generation platform for antibody drug discovery.See details»
Ablexis - Crunchbase
Ablexis is a biotechnology company developing an innovative, next-generation platform for antibody drug discovery.See details»
Codexis Announces First Revenue-Generating Contract for ECO …
Mar 24, 2025 Represents first project to enter the ECO Synthesis™ Innovation Lab Core enzymes for ECO Synthesis™ technology have transitioned from research into development …See details»
Ablexis, LLC
Ablexis’s AlivaMab Mouse AlivaMab Mouse is a trusted and validated platform for antibody drug discovery, in use by more than a dozen of the world’s top pharmaceutical companies, plus …See details»
Ablexis, AlivaMab Discovery Services, and Berkeley Lights …
Offers unique resources for COVID-19 therapeutic discovery SAN DIEGO and EMERYVILLE, Calif. – April 22, 2020 – Ablexis, LLC, AlivaMab Discovery Services, LLC ("ADS") and …See details»
Ablexis - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Ablexis is a biotechnology company developing an innovative, next-generation platform for antibody drug discovery.See details»